Results 121 to 130 of about 141,357 (291)

Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy

open access: yesPhytotherapy Research, EarlyView.
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee   +9 more
wiley   +1 more source

Quadruple-drug induction therapy in highly sensitized patients [PDF]

open access: yes, 1988
Abendroth, D.   +3 more
core   +1 more source

The polysaccharide Pullulan improves the initial steps of allergen‐specific immunotherapy in dogs

open access: yesVeterinary Record, EarlyView.
Abstract Background Allergen‐specific immunotherapy (AIT) is the only aetiological treatment for canine atopic dermatitis (CAD). Pullulan, a polysaccharide with immunomodulatory properties, may enhance AIT outcomes when combined with allergens such as recombinant Dermatophagoides farinae 2 (Der f 2).
Franco Martini   +3 more
wiley   +1 more source

Incidence of fistulas following human pancreas transplantation [PDF]

open access: yes, 1987
Abendroth, D.   +3 more
core   +1 more source

Regression of Post-transplant Kaposi′s sarcoma after Replacing Cyclosporine with Mycophenolate Mofetil

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2001
Kaposi′s sarcoma (KS) has been recently linked with human herpes virus-8 (HHV-8) infection. Other risk factors include the use of cyclosporine and polyclonal anti-lymphocyte sera.
Hussein Magdi   +2 more
doaj  

Outcome parameters in studies investigating dry eye disease: A systematic literature review

open access: yesActa Ophthalmologica, EarlyView.
Abstract The development of effective therapeutics for dry eye disease (DED) is challenging due to its complex pathophysiology, heterogeneous patient presentation and the significant failure rate of previous clinical development programs. This underlines the importance of the selection of appropriate endpoints for clinical trials.
Viktoria Pai   +8 more
wiley   +1 more source

Meta‐Analysis: Prevalence and Incidence of Gastroparesis Following Lung or Heart Transplantation

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Gastroparesis occurs in nearly one‐third of lung and heart‐lung transplant recipients (pooled prevalence 31.9%; incidence 25.7%), driven by surgical complexity, perioperative opioid exposure, and diagnostic criteria. Standardized gastric emptying assessment and multidisciplinary management, including opioid minimization, immunosuppressant optimization,
Mohamed H. Eldesouki   +9 more
wiley   +1 more source

Cyclosporin neurotoxicity [PDF]

open access: yesBritish Journal of Haematology, 2003
Bella, Patel, Ian, Kerridge
openaire   +2 more sources

Monovalent mannose‐glycoconjugates of sulforaphane reprogram human dendritic cells via NFATc1 to induce immune tolerance under inflammatory conditions

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Immune tolerance prevents inflammation and autoimmunity, with dendritic cells (DCs) playing a key role. Reprogramming DCs towards a tolerogenic state represents a promising therapeutic strategy. Sulforaphane (SFN) has known immunomodulatory effects, but its clinical application is limited by poor stability and ...
María Elena Angarita‐Planchez   +6 more
wiley   +1 more source

Real‐Life Workup of Chronic Hand Eczema Using a Dedicated Case Report Form: A SIDAPA Multicentre Study

open access: yesContact Dermatitis, EarlyView.
From January 2024 to May 2025, 207 patients (68.6% females) affected by CHE were enrolled to be clinically and etiologically investigated using a case report form specifically developed. The accurate workup led to clinical and etiological classification of CHE in about 80% of patients, allowing tailored treatment strategies. ABSTRACT Background Chronic
Rosella Gallo   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy